Physician profile
Preeti Gupta
NPI 1760447601
$1,316.99
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $256 · 2021: $139 · 2022: $93.87 · 2023: $47.48 · 2024: $46.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $182.04 | 2019-2020 | |
| Viiv Healthcare Company | $150.58 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $127.12 | 2019-2020 | |
| Abbott Laboratories | $112.22 | 2022-2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.13 | 2019-2021 | |
| Novo Nordisk INC | $86.60 | 2019-2022 | |
| Insmed, INC. | $69.87 | 2019-2020 | |
| Glaxosmithkline, LLC. | $64.11 | 2019 | |
| Amgen INC. | $63.67 | 2019-2022 | |
| Melinta Therapeutics, LLC | $59.94 | 2019 | |
| Lilly USA, LLC | $55.02 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $39.61 | 2019 | |
| Dexcom, INC. | $36.96 | 2021-2022 | |
| Allergan, INC. | $25.74 | 2019-2020 | |
| Abiomed | $24.78 | 2024 | Impella |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.87 | 2021 | |
| Astellas Pharma US INC | $18.96 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.68 | 2019 | |
| Dynavax Technologies Corporation | $17.81 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.75 | 2019 | |
| Shire North American Group INC | $16.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preeti Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.